Literature DB >> 16862553

Myotonic dystrophy expanded CUG repeats disturb the expression and phosphorylation of tau in PC12 cells.

Oscar Hernández-Hernández1, Mario Bermúdez-de-León, Pablo Gómez, Prisiliana Velázquez-Bernardino, Francisco García-Sierra, Bulmaro Cisneros.   

Abstract

Mental retardation is a main feature of the congenital form of myotonic dystrophy (DM1), however, the molecular mechanisms underlying the central nervous system symptoms of DM1 are poorly understood. We have established a PC12 cell line-based model expressing the DM1 expanded CUG repeats (CTG90 cells) to analyze the effects of this mutation on neuronal functions. Previously, we have reported that CTG90 cells displayed impaired NGF-induced neuronal differentiation. Because disruption of normal expression of the microtubule associated protein tau and neuronal aggregates of hyperphosphorylated tau have been associated with DM1, this study analyzes the behavior of tau in the CTG90 cells. Several alterations of tau were observed in the PC12 cells that express expanded CUG repeats, including a subtle but reproducible reduction in the expression of the tau mRNA splicing isoform containing exon 10, decreased expression of tau and hyperphosphorylation of both tau and high molecular weight tau as well as abnormal nuclear localization of tau phosphorylated at Ser396/404. Interestingly, phosphorylation regulates negatively the activity of tau as microtubule-associated protein. In addition, impaired activity of the Akt/GSK3beta pathway, which phosphorylates tau, was also identified in the CTG90 cells. Besides tau phosphorylation, the Akt/GSK3beta signaling pathway regulates other key processes of PC12 cells, such as apoptosis and neuronal differentiation. Our results indicate that defective neuronal differentiation exhibited by the PC12 cells expressing expanded CUG repeats could be the result of combinatory effects derived from the altered behavior of tau and the impaired activation of the Akt/GSK3beta signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16862553     DOI: 10.1002/jnr.20989

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  5 in total

1.  An SRp75/hnRNPG complex interacting with hnRNPE2 regulates the 5' splice site of tau exon 10, whose misregulation causes frontotemporal dementia.

Authors:  Yan Wang; Junning Wang; Lei Gao; Stefan Stamm; Athena Andreadis
Journal:  Gene       Date:  2011-06-30       Impact factor: 3.688

2.  Myotonic dystrophy type 1-associated CTG repeats disturb the expression and subcellular distribution of microtubule-associated proteins MAP1A, MAP2, and MAP6/STOP in PC12 cells.

Authors:  Prisiliana Velázquez-Bernardino; Francisco García-Sierra; Oscar Hernández-Hernández; Mario Bermúdez de León; Geneviève Gourdon; Mário Gomes-Pereira; Bulmaro Cisneros
Journal:  Mol Biol Rep       Date:  2011-05-13       Impact factor: 2.316

3.  Tau potentiates nerve growth factor-induced mitogen-activated protein kinase signaling and neurite initiation without a requirement for microtubule binding.

Authors:  Chad J Leugers; Gloria Lee
Journal:  J Biol Chem       Date:  2010-04-07       Impact factor: 5.157

4.  Perturbation of the Akt/Gsk3-β signalling pathway is common to Drosophila expressing expanded untranslated CAG, CUG and AUUCU repeat RNAs.

Authors:  Clare L van Eyk; Louise V O'Keefe; Kynan T Lawlor; Saumya E Samaraweera; Catherine J McLeod; Gareth R Price; Deon J Venter; Robert I Richards
Journal:  Hum Mol Genet       Date:  2011-04-25       Impact factor: 6.150

5.  High-content screening identifies small molecules that remove nuclear foci, affect MBNL distribution and CELF1 protein levels via a PKC-independent pathway in myotonic dystrophy cell lines.

Authors:  Ami Ketley; Catherine Z Chen; Xin Li; Sukrat Arya; Thelma E Robinson; Javier Granados-Riveron; Inyang Udosen; Glenn E Morris; Ian Holt; Denis Furling; Soraya Chaouch; Ben Haworth; Noel Southall; Paul Shinn; Wei Zheng; Christopher P Austin; Christopher J Hayes; J David Brook
Journal:  Hum Mol Genet       Date:  2013-10-30       Impact factor: 6.150

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.